New Treatment Option for Hemophilia B

At the American Society of Hematology Annual Conference, Carcao et al presented data on the safety and efficacy of nonacoge beta pegol (N9-GP) in children with hemophilia B. In this interview, Dr Manuel Carcao, MD, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada talks about the rationale behind the study and the impressive results that the study achieved. Reference Carcao M, Za M, Karim FA, et al. Safety, Efficacy and Pharmacokinetics of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Pediatric. Presented at American Society of Hematology Annual Meeting, Dec 6-9, 2014; San Francisco CA. Abstract 1513. https://ash.confex.com/ash/2014/webpr...